Politics

Boston Globe Endorses Adult-Use Legalization

Published on October 27, 2016 · Last updated July 28, 2020

In a surprising move, the Boston Globe has endorsed the Massachusetts cannabis legalization initiative, Question 4. In an op-ed published Thursday morning, the Globe editorial board announced its support of the initiative. Opponents of the measure, the paper argued, have “inadvertently provided the best reason to vote for the measure.”

Those opponents, which include political heavy hitters like Gov. Charlie Baker, Boston Mayor Marty Walsh, and Massachusetts Attorney General Maura Healey, have refused to consider legalizing and regulating cannabis through legislative action, and came out early against Question 4. Their opposition drove early negative opinion on the measure, but voters have swung the other way since early September. The most recent poll released on Oct. 19 has Question 4 leading 55 percent to 40 percent, with five percent undecided.

The Globe editorial board wrote that Question 4 could have been “better-crafted,” but the current initiative is all they’ve got to work with. And it’s a good start:

“The Globe endorses the yes campaign, despite the proposal’s many flaws, because the harm stemming from continued inaction on marijuana would be even greater.”

Massachusetts decriminalized cannabis possession in 2008, but state law left cannabis in a kind of “legal netherworld,” the Globe wrote, as it was legal to possess up to one ounce, but no one could legally sell it.

The newspaper isn’t exactly thrilled with the idea of legal cannabis. But its editorial board concluded that the harms of prohibition far outweigh the uncertain outcomes of regulated legalization:

“Using marijuana isn’t completely safe, and it isn’t completely harmless to others when users drive. But a social consensus is clearly emerging that pot’s real dangers just aren’t great enough to merit outlawing it anymore. While the authors of Question 4 could have written a much better law, they at least got the big picture right. Legal marijuana is coming. Let’s get on with it.”

Question 4 would create a legal marketplace for cannabis, creating thousands of jobs, and if done right, could end the illicit market. As the Globe mentions, the referendum calls for an unusually low 3.75 percent tax, on top of the normal state sales tax. The state’s legislature, the Globe argues, should look into raising the tax if the initiative passes.

Washington State’s cannabis excise tax is 37 percent; Colorado’s is 29 percent. California is proposing a 15 percent excise tax on adult-use cannabis in its Proposition 64.

The Globe noted that Massachusetts lawmakers have complained that improving the legal language in Question 4 would require them to clear time in their busy schedules. “Respectfully, today’s Legislature is by and large the same group of lawmakers who somehow found the time to write legislation for the horse-racing industry,” the paper responded. “They can survive the inconvenience that their constituents may impose on their calendars.”

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
Gage Peake
Gage Peake
Gage Peake is a former staff writer for Leafly, where he specialized in data journalism, sports, and breaking news coverage. He's a graduate of the University of Nebraska-Lincoln's College of Journalism and Mass Communications.
View Gage Peake's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.